816 related articles for article (PubMed ID: 28480062)
1. Locoregional and systemic therapy for hepatocellular carcinoma.
Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M
J Gastrointest Oncol; 2017 Apr; 8(2):215-228. PubMed ID: 28480062
[TBL] [Abstract][Full Text] [Related]
2. New concepts in embolotherapy of HCC.
Pesapane F; Nezami N; Patella F; Geschwind JF
Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
Kim DY; Han KH
Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
[TBL] [Abstract][Full Text] [Related]
4. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
[TBL] [Abstract][Full Text] [Related]
5. [Survival benefit with intraarterial techniques in hepatocellular carcinoma].
Sangro B
Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():95-101. PubMed ID: 25087719
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma.
Liu BJ; Gao S; Zhu X; Guo JH; Zhang X; Chen H; Wang XD; Yang RJ
World J Gastrointest Oncol; 2020 Jun; 12(6):663-676. PubMed ID: 32699581
[TBL] [Abstract][Full Text] [Related]
7. [Transarterial ablation of hepatocellular carcinoma. Status and developments].
Radeleff BA; Stampfl U; Sommer CM; Bellemann N; Hoffmann K; Ganten T; Ehehalt R; Kauczor HU
Radiologe; 2012 Jan; 52(1):44-55. PubMed ID: 22249701
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein.
Yu SJ; Kim YJ
World J Hepatol; 2015 Jun; 7(11):1553-61. PubMed ID: 26085914
[TBL] [Abstract][Full Text] [Related]
9. Management of hepatocellular in the United States.
Mokdad AA; Hester CA; Singal AG; Yopp AC
Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
11. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.
Khan AR; Wei X; Xu X
J Hepatocell Carcinoma; 2021; 8():1089-1115. PubMed ID: 34522691
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
Mahipal A; Tella SH; Kommalapati A; Lim A; Kim R
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31366113
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter embolization therapy in liver cancer: an update of clinical evidences.
Wáng YX; De Baere T; Idée JM; Ballet S
Chin J Cancer Res; 2015 Apr; 27(2):96-121. PubMed ID: 25937772
[TBL] [Abstract][Full Text] [Related]
14. Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab.
Adcock CS; Puneky LV; Campbell GS
Cureus; 2019 Feb; 11(2):e4083. PubMed ID: 31019861
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
16. Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma.
Paul SB; Sharma H
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S112-21. PubMed ID: 25755602
[TBL] [Abstract][Full Text] [Related]
17. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
18. Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.
Chai NX; Chapiro J
Semin Intervent Radiol; 2020 Dec; 37(5):456-465. PubMed ID: 33328701
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
Nishikawa H; Kita R; Kimura T; Osaki Y
Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]